Antivirals Global Market Report 2023

Feb 2023| TBR540D| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors
2) By Application: HIV; Hepatitis; Herpes; Influenza
3) By Type: Branded; Generic
Covering: AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd.; Gilead Sciences Inc.

Antivirals Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antivirals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for antivirals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antivirals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Drug Class, By Application, By Type
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	AbbVie Inc.; AstraZeneca plc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd.; Gilead Sciences Inc.; GlaxoSmithKline; Johnson & Johnson; Merck & Co., Inc.; Dr. Reddy’s Laboratories Ltd. Regeneron Pharmaceuticals, Inc.; Aurobindo Pharma; Abbott Laboratories; Schering-Plough Corporation; Pfizer Inc.; Sanofi; Novavax, Inc.; Inovio Pharmaceuticals, Inc.; BioCryst Pharmaceuticals, Inc.

Scope

Markets Covered:

By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Other Drug classes
By Application: HIV; Hepatitis; Herpes; Influenza; Other Applications
By Type: Branded; Generic

Companies Mentioned: AbbVie Inc.; Bristol-Myers-Squibb; Cipla ; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Anti-Viral Drug Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Anti-Viral Drug Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Anti-Viral Drug Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Anti-Viral Drug Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : China, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : India, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : Japan, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : Australia, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : Indonesia, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : South Korea, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Western Europe, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : UK, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Germany, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : France, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Eastern Europe, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : Russia, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : North America, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : USA, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : South America, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : Brazil, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : Middle East, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Africa, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : AbbVie Inc. Financial Performance
Table 28 : Bristol-Myers-Squibb Financial Performance
Table 29 : Cipla Financial Performance
Table 30 : F. Hoffmann-La Roche Ltd Financial Performance
Table 31 : Gilead Sciences Inc Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Anti-Viral Drug Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Anti-Viral Drug Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Anti-Viral Drug Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Anti-Viral Drug Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : China, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : India, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : Japan, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : Australia, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : Indonesia, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : South Korea, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Western Europe, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : UK, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Germany, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : France, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Eastern Europe, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : Russia, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : North America, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : USA, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : South America, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : Brazil, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : Middle East, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Africa, Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : AbbVie Inc. Financial Performance
Figure 28 : Bristol-Myers-Squibb Financial Performance
Figure 29 : Cipla Financial Performance
Figure 30 : F. Hoffmann-La Roche Ltd Financial Performance
Figure 31 : Gilead Sciences Inc Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Antivirals Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR540C

Including: 1) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others
2) By Application: HIV; Hepatitis; Herpes; Influenza; Others
3) By Type: Branded; Generic
Covering: AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd.; Gilead Sciences Inc.; GlaxoSmithKline; Johnson & Johnson; Merck & Co., Inc.

Antivirals Global Market Report 2022 from The Business Research Company ...

Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030

Published Date - Jun 2021
Report Code - TBR540B

Covering: AbbVie Inc.; Bristol-Myers-Squibb; Cipla; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc.

Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030 from The Business Research Company covers this ...

Antivirals Global Market Report 2020

Published Date - Nov 2019
Report Code - TBR540A

Including: 1) By Therapeutics: HIV/AIDS Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics, Influenza Therapeutics, Others (Pneumonia) 2) By End User: Hospitals, Clinics, Ambulatory surgical center 3) By Target: DNA polymerase, NS3 Protease, Reverse transcriptase, Others 4) By Drug Type: Generic, Branded

Covering: Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc, Roche Holding AG, Gilead Sciences